UBS ASSET MANAGEMENT AMERICAS INC - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 385 filers reported holding GLOBUS MED INC in Q3 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$9,035,805
+40.6%
181,990
+60.4%
0.00%
+33.3%
Q2 2023$6,427,3370.0%113,4770.0%0.00%0.0%
Q1 2023$6,427,337
-28.4%
113,477
-6.2%
0.00%
-40.0%
Q4 2022$8,981,249
-99.9%
120,927
+3.4%
0.01%
+25.0%
Q3 2022$6,969,273,000
-13.4%
116,993
-18.4%
0.00%0.0%
Q2 2022$8,049,971,000
-13.3%
143,391
+14.0%
0.00%0.0%
Q1 2022$9,282,189,000
-3.3%
125,809
-5.4%
0.00%0.0%
Q4 2021$9,601,082,000
-5.9%
132,979
-0.2%
0.00%0.0%
Q3 2021$10,206,551,000
-3.5%
133,210
-2.3%
0.00%
-20.0%
Q2 2021$10,575,169,000
+31.9%
136,401
+5.0%
0.01%
+25.0%
Q1 2021$8,014,879,000
-10.8%
129,964
-5.7%
0.00%0.0%
Q4 2020$8,989,925,000
+41.6%
137,840
+7.5%
0.00%
+33.3%
Q3 2020$6,347,918,000
+12.0%
128,189
+7.9%
0.00%0.0%
Q2 2020$5,666,564,000
+3.6%
118,771
-7.7%
0.00%
-25.0%
Q1 2020$5,471,825,000
-30.1%
128,658
-3.2%
0.00%
-20.0%
Q4 2019$7,828,684,000
-2.4%
132,960
-15.3%
0.01%0.0%
Q3 2019$8,020,627,000
+29.2%
156,898
+6.9%
0.01%
+25.0%
Q2 2019$6,207,948,000
-42.3%
146,760
-32.6%
0.00%
-50.0%
Q1 2019$10,759,076,000
+15.3%
217,751
+1.0%
0.01%0.0%
Q4 2018$9,327,359,000
-24.7%
215,512
-1.3%
0.01%
-11.1%
Q3 2018$12,393,092,000
+12.3%
218,342
-0.2%
0.01%
+12.5%
Q2 2018$11,035,804,000
-0.1%
218,704
-1.3%
0.01%
-11.1%
Q1 2018$11,044,746,000
+20.9%
221,693
-0.3%
0.01%
+12.5%
Q4 2017$9,137,969,000
+48.9%
222,335
+7.7%
0.01%
+33.3%
Q3 2017$6,136,913,000
-10.4%
206,491
-0.1%
0.01%
-14.3%
Q2 2017$6,850,646,000
+14.7%
206,656
+2.5%
0.01%
+16.7%
Q1 2017$5,972,429,000
+155432.0%
201,635
+30.3%
0.01%
+50.0%
Q4 2016$3,840,000
+37.2%
154,778
+24.8%
0.00%
+33.3%
Q3 2016$2,799,000
+9.2%
124,022
+15.3%
0.00%0.0%
Q2 2016$2,564,000
-2.3%
107,592
-2.6%
0.00%0.0%
Q1 2016$2,625,000
+4.0%
110,517
+21.9%
0.00%0.0%
Q4 2015$2,523,000
+178.5%
90,681
+106.7%
0.00%
+200.0%
Q3 2015$906,000
+5.1%
43,861
+30.7%
0.00%0.0%
Q2 2015$862,000
+60.2%
33,561
+57.6%
0.00%0.0%
Q1 2015$538,000
+10.9%
21,300
+4.4%
0.00%
Q4 2014$485,000
+31.8%
20,400
+9.1%
0.00%
Q3 2014$368,000
-17.7%
18,7000.0%0.00%
Q2 2014$447,000
-4.5%
18,700
+6.2%
0.00%
Q1 2014$468,000
+32.6%
17,600
+0.6%
0.00%
Q4 2013$353,000
+23.9%
17,500
+7.4%
0.00%
Q3 2013$285,000
+3.6%
16,3000.0%0.00%
Q2 2013$275,00016,3000.00%
Other shareholders
GLOBUS MED INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders